Lundbeck to buy Longboard Pharma in $2.6 billion deal

H Lundbeck A/S

14/10/2024 11:35

Oct 14 (Reuters) - H Lundbeck A/S  HLUNb.CO  has agreed
to buy US-based Longboard Pharmaceuticals  LBPH.O  in a $2.6
billion deal to boost its pipeline of treatments for neuro-rare
conditions, the companies said on Monday. 

 (Reporting by Manas Mishra in Bengaluru; Editing by Shinjini
Ganguli)
 ((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manaswrites15;))